A pharmaceutical company that jacked up the price of a live-saving medication is charging too much and must lower it, says Canada’s drug price agency.

This entry was posted on Friday, September 30th, 2022 at 7:19 am and is filed under Finance/ Money. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.